Premenstrual Syndrome. Unspecified condition associated with female genital organs and menstrual cycle
Conditions
Interventions
Intervention 1: Five finger test group oral drops to 40 drops a day for three menstrual cycles. Intervention 2: A placebo control group, the intervention takes place.
Treatment - Drugs
Placebo
Five finger test group oral drops to 40 drops a day for three menstrual cycles
A placebo control group, the intervention takes place
Sponsors
Ahvaz University Of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 25 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: students with premenstrual syndrome with regular menstrual cycle. exclusion criteria: Psychotherapy with pregnancy or breastfeeding; use of hormones; stress in the recent quarter such as marriage or the death of someone close surgery; patients taking certain medications such as dopamine antagonists used
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The severity of the symptoms of premenstrual syndrome. Timepoint: one? two Three months after intervention. Method of measurement: Recorded daily symptoms of PMS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects include itching, dizziness, stomach pain, diarrhea. Timepoint: Two weeks until 1 mounth. Method of measurement: Phone calls and monthly views. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParvaneh Mousavi
Ahvaz University of Medical Sciences
Outcome results
None listed